In addition to proteomic alterations, such as tyrosine phosphorylation, in the pathogenesis of ischemic stroke, growth factors or neurotrophic factors, including IGF, FGF, and BDNF, can reduce cell damage by inhibiting the tyrosine kinase receptor-activated apoptosis pathway [45]. The gene discussed is BDNF; the disease is ischemic stroke.